The cost of treating hypertension: Can we keep it under control without compromising the level of care?

American Journal of Hypertension

Volumn 11, Issue 8 II SUPPL., 1998, Pages

  Moser, Marvin ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Clinical trials; Cost; Hypertension; Quality of care

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; BEHAVIOR MODIFICATION; BLOOD PRESSURE MONITORING; DRUG COST; ECHOCARDIOGRAPHY; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; HYPERTENSION; LIFESTYLE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; REVIEW; TREATMENT OUTCOME;

EID: 0031846679     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(98)00106-x     Document Type: Review

References (29)

1. Joint National Committee: Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC I). JAMA 1977;237:255-261.
2. Joint National Committee: Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC II). Arch Intern Med 1980; 140:1280-1285.
3. Joint National Committee: Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC III). Arch Intern Med 1984; 144:1045-1057.
4. Joint National Committee: Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC IV). Arch Intern Med 1988; 148:1023-1038.
5. Joint National Committee: Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993; 153:154-183.
6. Joint National Committee: Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC VI): Arch Intern Med 1997; 157:2413-2446.
7. Gottdiener JS, Reda DJ, Massie BM, et al: Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents; the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Circulation 1997;95:2007-2014.
8. Neaton JD, Grimm RH, Prineas RJ, et al: for the Treatment of Mild Hypertension Study Research Group: Treatment of mild hypertension study: final results. JAMA 1993;270:713-724.
9. Sheps SG, Frohlich ED: Limited echocardiography for hypertensive left ventricular hypertrophy. Hypertension 1997;29:560-563.
10. Pickering T, for an American Society of Hypertension Ad Hoc Panel: Recommendations for the use of home (self) and ambulatory blood pressure monitoring. Am J Hypertens 1995;9:1-11.
11. Julius S, Mejia A, Jones K, et al: "White coat" versus "sustained" borderline hypertension in Tecumseh, Michigan. Hypertension 1990;16:617-623.
12. Kannel WB: Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA 1996;275:1571-1576.
13. Hypertension Detection and Follow-up Program Cooperative Group: Five-year findings of the Hypertension Detection and Follow-up Program: 1. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1979;242:2562-2567.
14. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-3264.
15. Perloff D, Sokolow M, Cowan R: The prognostic value of ambulatory blood pressures. JAMA 1983;249:2792-2798.
16. Verdecchia P, Porcellati C, Schillaci G, et al: Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension 1994;24: 793-801.
17. Burt VL, Cutler JA, Higgins M, et al: Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: data from the health examination surveys, 1960 to 1991. Hypertension 1995;26:60-69.
18. Moser M: Management of hypertension, Part I. Am Family Physician 1996;53:2295-2302.
19. Moser M: Hypertension, in Rakel R (ed): Conn's Curent Therapy. W.B. Saunders Co., Philadelphia, 1995, pp 263-280.
20. Moser M: Management of hypertension, Part II. Am Family Physician 1996;53:2553-2560.
21. Moser M: Angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists and calcium channel blocking agents: a review of potential benefits and possible adverse reactions. J Am Coll Cardiol 1997;29: 1414-1421.
22. Staessen JA, Fagard R, Thijs L, et al, for the Systolic Hypertension Europe (Syst-Eur) Trial Investigators: Morbidity and mortality in the placebo-controlled European Trial on Isolated Systolic Hypertension in the Elderly. Lancet 1997;350:757-764.
23. Hebert PR, Moser M, Mayer J, Hennekens CH: Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med 1993;153:578-581.
24. Moser M, Hebert P: Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 1996;27:1214-1218.
25. Hypertension Detection and Follow-up Program Cooperative Group: Persistemce of reduction in blood pressure and mortality of participants in the Hypertension Detection and Follow-up Program. JAMA 1988;259: 2113-2112.
26. The Multiple Risk Factor Intervention Trial Research Group: Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial. JAMA 1990;263:1795-1801.
27. Australian National Blood Pressure Management Committee: The Australian therapeutic trial in mild hypertension. Lancet 1980;i:1261-1267.
28. European Working Party on High Blood Pressure in the Elderly: Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly. Lancet 1985;i:1349-1354.
29. Grimm RH Jr, Grandits GA, Cutler JA, et al, for the TOMHS Research Group: Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study. Arch Intern Med 1997;157:638-648.